Dennis O’Brien

587 total citations
16 papers, 455 citations indexed

About

Dennis O’Brien is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Electrical and Electronic Engineering. According to data from OpenAlex, Dennis O’Brien has authored 16 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Electrical and Electronic Engineering. Recurrent topics in Dennis O’Brien's work include Lung Cancer Treatments and Mutations (6 papers), HER2/EGFR in Cancer Research (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Dennis O’Brien is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), HER2/EGFR in Cancer Research (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Dennis O’Brien collaborates with scholars based in United States, United Kingdom and Germany. Dennis O’Brien's co-authors include Uz Stammberger, Martina Uttenreuther‐Fischer, J.R. Bowen, James Harris, Mario E. Lacouture, Jana Barinoff, Chia‐Yu Chu, James Chih‐Hsin Yang, Axel Hauschild and Dirk Schadendorf and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of Applied Physics.

In The Last Decade

Dennis O’Brien

16 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis O’Brien United States 10 166 154 107 106 47 16 455
Peng Yuan China 16 93 0.6× 216 1.4× 44 0.4× 188 1.8× 150 3.2× 67 715
Keiji Imai Japan 8 79 0.5× 136 0.9× 8 0.1× 95 0.9× 17 0.4× 15 391
Yanbing Liu China 12 136 0.8× 46 0.3× 44 0.4× 100 0.9× 71 1.5× 41 534
G. Baldo Italy 15 96 0.6× 35 0.2× 91 0.9× 183 1.7× 158 3.4× 29 683
Yasushi Fujioka Japan 14 188 1.1× 76 0.5× 24 0.2× 106 1.0× 43 0.9× 27 536
Matej Horvat Slovenia 12 63 0.4× 53 0.3× 13 0.1× 48 0.5× 43 0.9× 32 383
Zhihuan Li China 9 76 0.5× 52 0.3× 17 0.2× 210 2.0× 29 0.6× 43 523
Y. Sakai Japan 9 234 1.4× 163 1.1× 12 0.1× 189 1.8× 99 2.1× 29 510
Makoto Kanno Japan 12 140 0.8× 36 0.2× 3 0.0× 177 1.7× 65 1.4× 44 662

Countries citing papers authored by Dennis O’Brien

Since Specialization
Citations

This map shows the geographic impact of Dennis O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis O’Brien more than expected).

Fields of papers citing papers by Dennis O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis O’Brien. The network helps show where Dennis O’Brien may publish in the future.

Co-authorship network of co-authors of Dennis O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis O’Brien. A scholar is included among the top collaborators of Dennis O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis O’Brien. Dennis O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ball, Greg, Barbara A. Hendrickson, J.R. Buchanan, et al.. (2020). Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions. Therapeutic Innovation & Regulatory Science. 54(2). 447–461. 6 indexed citations
2.
Edwards, Rebecca, et al.. (2018). Afatinib Therapy: Practical Management of Adverse Events With an Oral Agent for Non-Small Cell Lung Cancer Treatment. Clinical journal of oncology nursing. 22(5). 542–548. 14 indexed citations
3.
Ewer, Michael S., et al.. (2015). Cardiac safety of afatinib: a review of data from clinical trials. Cardio-Oncology. 1(1). 3–3. 24 indexed citations
4.
Feng, Jianyuan, et al.. (2015). Smart grid coordination of a chemical processing plant. Chemical Engineering Science. 136. 168–176. 12 indexed citations
5.
Wu, Yi‐Long, Sarayut Lucien Geater, Tony Mok, et al.. (2014). Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A). International Journal of Radiation Oncology*Biology*Physics. 90(5). S41–S41. 1 indexed citations
6.
Ewer, Michael S., et al.. (2014). Cardiac safety of afatinib: Review of clinical trial data.. Journal of Clinical Oncology. 32(15_suppl). e19037–e19037. 2 indexed citations
7.
Lacouture, Mario E., Dirk Schadendorf, Chia‐Yu Chu, et al.. (2013). Dermatologic adverse events associated with afatinib: an oral ErbB family blocker. Expert Review of Anticancer Therapy. 13(6). 721–728. 69 indexed citations
8.
Yang, James Chih‐Hsin, Noemı́ Reguart, Jana Barinoff, et al.. (2013). Diarrhea associated with afatinib: an oral ErbB family blocker. Expert Review of Anticancer Therapy. 13(6). 729–736. 88 indexed citations
9.
10.
Stein, Evan A., et al.. (2011). Lapaquistat Acetate. Circulation. 123(18). 1974–1985. 54 indexed citations
11.
12.
Harris, James, et al.. (2002). Reduce Costs with Dividing-Wall Columns. Chemical engineering progress. 98(5). 64–71. 106 indexed citations
13.
Boughton, B. J., et al.. (1995). High-Performance Liquid Chromatographic Assay of Plasma Thalidomide: Stabilization of Specimens and Determination of a Tentative Therapeutic Range for Chronic Graft-Versus-Host Disease. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 32(1). 79–83. 16 indexed citations
14.
Carr, Albert A., Peter B. Bottini, L. Michael Prisant, et al.. (1991). Once‐Daily Verapamil in the Treatment of Mild‐to‐Moderate Hypertension: A Double‐Blind Placebo‐Controlled Dose‐Ranging Study. The Journal of Clinical Pharmacology. 31(2). 144–150. 16 indexed citations
15.
O’Brien, Dennis & J.R. Bowen. (1971). Parametric Studies of the Iodine Photodissociation Laser. Journal of Applied Physics. 42(3). 1010–1015. 5 indexed citations
16.
O’Brien, Dennis & J.R. Bowen. (1969). Kinetic Model for the Iodine Photodissociation Laser. Journal of Applied Physics. 40(12). 4767–4769. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peng Yuan Breakdown of academic impact, for papers by Keiji Imai Breakdown of academic impact, for papers by Yanbing Liu Breakdown of academic impact, for papers by G. Baldo Breakdown of academic impact, for papers by Yasushi Fujioka Breakdown of academic impact, for papers by Matej Horvat Breakdown of academic impact, for papers by Zhihuan Li Breakdown of academic impact, for papers by Y. Sakai Breakdown of academic impact, for papers by Makoto Kanno
Rankless by CCL
2026